Figure 1.

Illustration of various pharmacological therapies proposed and investigated to treat COVID-19 patients classified as two categories: antiviral approach and anti-inflammatory approach. The antiviral approach includes the use of agents that block viral binding, entry, fusion, RNA duplication, viral assembly, or exocytosis. The anti-inflammatory approach includes the application of agents that inhibit various inflammatory pathways, reduce cytokine production, and block cytokine receptors. Reproduced with permission from the publisher [4].